Extending the synthetic utility of 1,4-oxazin-2-ones and 2,5-diketopiperazines
扩展 1,4-恶嗪-2-酮和 2,5-二酮哌嗪的合成用途
基本信息
- 批准号:9812348
- 负责人:
- 金额:$ 34.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-01 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcidsAcuteAddressAlkaloidsAreaAwardBiologicalBiomedical ResearchCatalysisChemicalsChemistryClimateComplexDevelopmentDoctor&aposs DegreeEducational process of instructingErbB4 geneEvaluationFoundationsInvestigationLateralMethodsMolecularNeuregulinsNeuritesOne-Step dentin bonding systemPhysical condensationPreparationProcessPyrrolesReactionResearchResearch PersonnelResourcesScienceStructureStudentsSystemTargeted ResearchTimeTrainingUnited States National Institutes of Healthanti-cancercollegecost efficientcycloadditiondesigndiketopiperazinedirect applicationeducational atmosphereexperienceexperimental studyinhibitor/antagonistmolecular assembly/self assemblyprogramspyridinepyrrolinescaffoldundergraduate student
项目摘要
Project Summary
This proposal describes the development of new methods for the preparation of 1,4-oxazin-2-
one precursors and seeks to apply these intermediates to the construction of highly substituted
pyridine products through a merged cycloaddition/cycloreversion process. The investigation of
oxazinones will increase our understanding of the fundamental reactivity of this underutilized
heterocyclic ring system. Additionally, pyridines are one of the most prevalent structures
imbedded within biologically active molecules. Thus, new methods for the construction of
pyridine motifs (especially those not easily prepared through condensation methods) is merited
and is acutely significant to the biomedical sciences. Where possible, domino reaction
processes are included that are economical with regard to time, are resource and cost efficient,
and serve to rapidly generate molecular complexity. The proposed foundational experiments
probe some of the potentially superior features of oxazinones relative to other [4+2]/retro[4+2]
heterocycles used in pyridine synthesis. Applications directed toward the synthesis of
biologically relevant pyridines are included in the proposal to showcase enabling features of the
oxazinone scaffold: (1) a one-step multi component synthesis of a compound effecting neurite
differentiation and (2) a unified synthesis strategy toward the guaipyridine alkaloids (including
the anticancer compound cananodine and rupestines).
A second objective of the proposal seeks to advance useful synthetic transformations starting
from alkylidene 2,5-diketopiperazines. In particular, this proposal seeks to establish reliable
methods for the synthesis of 1,2-carbonyl products and pyrrole- and dihydropyrrole-fused
diketopiperazine structures. These products are valuable both as bioactive compounds or can
be important precursors for the elaboration to more complex structures.
The College of William & Mary does not offer a doctoral degree in chemistry (BS/MS only);
accordingly, my research group is composed of undergraduate researchers (and one MS
candidate). My current research program creates a rigorous environment for learning and
enforces teaching and training in the one-on-one research experience. The proposed research
would continue within this climate and is designed at an appropriate level for students to make
progress. Support from the NIH would enable the research of 3-4 undergraduates and one
Master's candidate for each year of the award.
项目摘要
该提案描述了制备1,4-恶嗪-2-酮的新方法的开发。
一种前体,并试图将这些中间体应用于构建高度取代的
吡啶产物通过合并的环加成/环逆转过程。调查
恶嗪酮类将增加我们对这种未充分利用的基本反应性的理解,
杂环系统。此外,吡啶是最常见的结构之一,
嵌入在生物活性分子中因此,新方法的建设,
吡啶基序(特别是那些不容易通过缩合方法制备的基序)是值得的
对生物医学科学有着重大意义。在可能的情况下,多米诺骨牌反应
所包括的工艺在时间方面是经济的,是资源和成本有效的,
并用于快速产生分子复杂性。拟议的基础实验
探索恶嗪酮类相对于其他[4+2]/反式[4+2]的一些潜在上级特征
用于吡啶合成的杂环。针对合成的应用
生物相关的吡啶类化合物被列入提案,以展示
恶嗪酮支架:(1)影响神经突的化合物的一步多组分合成
分化和(2)一个统一的合成策略对愈创木吡啶生物碱(包括
抗癌化合物cananodine和rupestines)。
该提案的第二个目标是促进有用的合成转化,
由亚烷基2,5-二酮哌嗪制得。特别是,这项建议旨在建立可靠的
合成1,2-羰基产物和吡咯-和二氢吡咯-稠合物的方法
二酮哌嗪结构。这些产物作为生物活性化合物或可
成为更复杂结构的重要前体。
威廉和玛丽学院不提供化学博士学位(仅限BS/MS);
因此,我的研究小组是由本科研究人员(和一个MS
候选人)。我目前的研究计划创造了一个严格的学习环境,
在一对一的研究经验中加强教学和培训。拟议研究
将继续在这种气候下,并在适当的水平,为学生设计,
中求进工作总NIH的支持将使3-4名本科生和1名
每年的硕士候选人奖。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jonathan R Scheerer其他文献
Jonathan R Scheerer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jonathan R Scheerer', 18)}}的其他基金
Cycloadditions and cycloreversions of pyrazinones: preparation of diverse medicin
吡嗪酮的环加成和环化回复:多种药物的制备
- 批准号:
8755465 - 财政年份:2014
- 资助金额:
$ 34.25万 - 项目类别:
New methods to prepare 1,4-oxazin-2-ones and applications in the construction of polysubstituted pyridines
1,4-恶嗪-2-酮的制备新方法及其在多取代吡啶构建中的应用
- 批准号:
10794499 - 财政年份:2014
- 资助金额:
$ 34.25万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 34.25万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 34.25万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 34.25万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 34.25万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 34.25万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 34.25万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 34.25万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 34.25万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 34.25万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 34.25万 - 项目类别:
Standard Grant